Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, Schulick R, Winter J, Herman JM, Laheru D, Klein AP, Vogelstein B, Kinzler KW, Velculescu VE, Hruban RH. Blackford A, et al. Among authors: jaffee em. Clin Cancer Res. 2009 Jul 15;15(14):4674-9. doi: 10.1158/1078-0432.CCR-09-0227. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584151 Free PMC article.
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma.
Jaffee EM, Abrams R, Cameron J, Donehower R, Duerr M, Gossett J, Greten TF, Grochow L, Hruban R, Kern S, Lillemoe KD, O'Reilly S, Pardoll D, Pitt HA, Sauter P, Weber C, Yeo C. Jaffee EM, et al. Hum Gene Ther. 1998 Sep 1;9(13):1951-71. doi: 10.1089/hum.1998.9.13-1951. Hum Gene Ther. 1998. PMID: 9741433 Clinical Trial. No abstract available.
Use and benefits of a Web site for pancreatic cancer.
Goggins M, Lietman A, Miller RE, Yeo CJ, Jaffee E, Coleman J, O'Reilly S, Cullen B, Cameron JL, Kern SE, Hruban RH. Goggins M, et al. JAMA. 1998 Oct 21;280(15):1309-10. doi: 10.1001/jama.280.15.1309-a. JAMA. 1998. PMID: 9794306 No abstract available.
Potential role of tumor vaccines in GI malignancies.
Laheru DA, Jaffee EM. Laheru DA, et al. Among authors: jaffee em. Oncology (Williston Park). 2000 Feb;14(2):245-56; discussion 259-60, 265. Oncology (Williston Park). 2000. PMID: 10736811 Free article. Review.
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O'Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL. Chakravarthy A, et al. Among authors: jaffee em. Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1089-96. doi: 10.1016/s0360-3016(00)00755-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 11072167 Free article.
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation.
Jaffee EM, Hruban RH, Biedrzycki B, Laheru D, Schepers K, Sauter PR, Goemann M, Coleman J, Grochow L, Donehower RC, Lillemoe KD, O'Reilly S, Abrams RA, Pardoll DM, Cameron JL, Yeo CJ. Jaffee EM, et al. J Clin Oncol. 2001 Jan 1;19(1):145-56. doi: 10.1200/JCO.2001.19.1.145. J Clin Oncol. 2001. PMID: 11134207 Clinical Trial.
327 results